Adam Urato: How SSRIs May Affect Maternal and Fetal Serotonin
Adam Urato, Maternal-Fetal Medicine Physician at MetroWest Medical Center, shared a post on X about a recent article by Amy L. Salisbury et al., published in Neuropsychopharmacology, adding:
“SSRIs have profound chemical impact on the pregnant mom and her baby.
This study showed an EIGHT-fold reduction in mom’s platelet serotonin, and FOUR-fold decrease in baby’s.
Lower serotonin levels were associated with more abnormal (fidgety/restless) fetal movements on ultrasound.”
Title: Fetal behavior and gestational serotonin reuptake inhibitor exposure: relationships between behavior, drug dosage, plasma drug level, and a measure of drug bioeffect
Authors: Amy L. Salisbury, George M. Anderson, Amy Yang, Catherine S. Stika, Laura J. Rasmussen-Torvik, Jacqueline K. Gollan, Katherine L. Wisner

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments
-
Nov 16, 2026, 12:44Stefan Prendić: How Intronic Variants Affect Rh Blood Group Antigen Expression
-
Nov 16, 2026, 12:26Samwel Mikaye: Understanding Warfarin and Its Clinical Management
-
Nov 16, 2026, 12:14Sophia Delicou: Ensuring Lifelong Health Beyond Stem Cell Transplantation
-
Nov 16, 2026, 12:06Edward Lee Carter: Has PEPPER Changed the Role of Aspirin in Arthroplasty VTE Prophylaxis?
-
Nov 16, 2026, 11:53Eduardo Ortiz Bello: The Endothelium in Hemostasis and Microcirculation
-
Nov 16, 2026, 11:51Phil Spinella: Advancing Transfusion Medicine Through Collaboration